13th edition

Format
HYBRID

December 3rd & 4th, 2024

IN-PERSON | LILLE, FR

December 11th& 12th 2024

ONLINE MEETINGS

Nadège Joly

Come hear them speak at BioFIT 2018!

They will speak at BioFIT 2018:

  • Jan Adams, Managing Director, EMBL Ventures (DE)
  • Anjan Aralihalli, Venture Partner, CTI Life Sciences Fund II (CA)
  • Caroline Barelle, CEO, Elasmogen (UK)
  • Yann Barrault, Head of Business Development & Licensing, SATT Grand Centre (FR)
  • Jean-Charles Brosse, Partner Healthcare & Life Sciences, Positive Capital (FR)
  • Alain Chevallier, Life Sciences Partner, Truffle Capital (FR)
  • Lucie Ellis, Senior Editor, Pharma Intelligence | Informa (UK)
  • Juan Garcia, CEO, BioSeed Capital (ES)
  • George Hoffman, Co-founder and CEO, Network Immunology (US)
  • Adrian Ibrahim, Head of Technology Transfer, Wellcome Sanger Institute (UK)
  • Steven J. Klein, Vice President, Business Development, IRICoR – Institute for Research in Immunology and Cancer-Commercialization of Research (CA)
  • Peter Leonardi, CEO, OmniCyte (US)
  • Michael Motz, CBO, NETRIS Pharma (FR)
  • Michael L. Salgaller, Supervisor, Invention Development and Marketing Unit, National Institutes of Health (NIH) | National Cancer Institute (NCI) | Technology Transfer Center (US)
  • Bernd Stowasser, Head of Alliance Management Germany & Global Public Private Partnerships, Sanofi (DE)
  • Jonathan Tobin, Investment Director, Arix Bioscience (UK)
  • Ewa Truchanowicz, Life Sciences Lead, University of Birmingham Enterprise (UK)
  • Bram Vanparys, Investment Director, MS Ventures (NL)
Want to join them?
Discover the conference programme

Come hear them speak at BioFIT 2018! Read More »

We are very honoured to count Boehringer Ingelheim among the Sponsors of BioFIT 2018

Many thanks to Boehringer Ingelheim for joining BioFIT 2018 as a Bronze Sponsor!

Innovative medicines for people and animals have for more than 130 years been what the research-driven pharmaceutical company Boehringer Ingelheim stands for. Boehringer Ingelheim  is one of the pharmaceutical industry’s top 20 companies and to this day remains family-owned. Day by day, some 50,000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing.

Join this key BioFIT 2018 sponsor to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

For more information about the sponsorship opportunities, visit the dedicated site page.

We are very honoured to count Boehringer Ingelheim among the Sponsors of BioFIT 2018 Read More »

[VIDEO] They were at #BioFIT2017: Future Worlds

After an exciting and successful first day at BioFIT 2017, the Future Worlds team arrived early on Wednesday morning at the Palais de la Musique et des Congrès convention centre, ready for another energetic day at Europe’s leading life sciences partnering event in Strasbourg. After filming some footage for the blog of the buzzing convention centre, Brigitte and I interviewed our resident stand spinout Dr Agnieszka Janeczek of Renovos in our second …

Read the whole article on FuturaWorlds.com

Watch the video made by Future Worlds:

Future Worlds is a startup platform and business incubator championing the innovative commercial opportunities being developed by researchers and students at the University of Southampton.

[VIDEO] They were at #BioFIT2017: Future Worlds Read More »

#BioFIT2017 was a success: Thank you!

1,200 delegates, over 30 countries represented, 100 exhibitors, 80 international speakers, 15 roundtable discussions and 3 hosted events: With these figures, BioFIT renewed during this 6th edition its position as the leading event for tech transfer, academia-industry collaborations and early-stage innovation in the field of Life Sciences and has become the marketplace for pre-seed, seed and Series A investment. BioFIT gathers big pharma, biotech start-ups and SMEs, researchers and investors in the same place at the same time, focused on the same goals: Engage new partnerships, source innovative and competitive early stage R&D projects, facilitate the emergence of collaborative projects and increase licensing opportunities in Life Sciences.

BioFIT 2017 was once again an unmissable event for the actors from the Life Sciences sector. In sixth editions, BioFIT has quadrupled its number of attendees from 300 to 1,200, convinced every year more and more organisations to host their events.

To continue its growth, the organisers of BioFIT have decided to engage in a long-term partnership with the Alsace BioValley competitiveness cluster offering for the BioFIT participants 2 ideal locations at the crossroads of Europe. The Lille-Strasbourg alternation began in 2015 and was reinforced this year by the second edition in the Grand Est Region.

To put it in a nutshell, BioFIT allows sourcing early-stage innovations, encourages collaborations between academic and industrial sectors and provides keys to gain insight the news from the sector thanks to its 4 main activities: One-to-one meetings, conferences and roundtable discussions, presentation sessions and exhibition.

We are looking forward to seeing you again in Lille on 4th – 5th December 2018 for the 7th edition!

 

 

#BioFIT2017 was a success: Thank you! Read More »

Discover the Start-ups that will pitch on BioFIT 2017!

Discover below and during the Start-ups Slams the most innovative start-ups in specific fields

28th Nov. 2.30-4.00 pm | Innov’ Area

Vascular & Metabolic

  • OP2LYSIS
  • CARDIOR PHARMACEUTICALS
  • EMOSIS
  • APTAMIR THERAPEUTICS

Vaccinology & Virology

  • VAXIANO
  • VIRELIEVE
  • PAR’IMMUNE

29th Nov. 9.00-10.30 am | Innov’ Area

Oncology & Immuno-onco

  • STIPE THERAPEUTICS
  • ELTHERA
  • THERANOVIR
  • CHROMALYS

29th Nov. 2.00-3.30 pm | Innov’ Area

Research tools & Therapeutic Delivery

  • MECACHIPS
  • DYNABIND
  • SIMPLICITYBIO
  • RENOVOS

Ageing & Pain

  • INNOPAIN
  • PRAGMA THERAPEUTICS
  • REMINISCIENCES
More information about the Start-up Slams

Discover the Start-ups that will pitch on BioFIT 2017! Read More »

Many thanks to Merck for its support in BioFIT 2017

We are very honoured to count Merck among the Sponsors of BioFIT.

 

Join key BioFIT 2017 sponsors such as PfizerLillyRocheMSDBoehringer Ingelheim, Johnson & Johnson Inovation, Novo Nordisk, LFB, PPRS and Trianni to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools
Discover all the sponsorship opportunities

Please contact us to receive a tailored offer that best meets your requirements!

Many thanks to Merck for its support in BioFIT 2017 Read More »

Check out BioFIT 2017’s hosted event

BioFIT will host the 3rd edition of the “R&D dating for animal health and innovation” initiated by SIMV, the French association for animal health industry, on 28th and 29th November 2017, in Strasbourg.

Today, public-private and private-private partnerships are thought to be the needed leverage for innovation. Hence, the SIMV (the French association for the animal health industry) launched the “R&D dating for Animal Health and innovation” which aims at initiating high-level exchanges between the research departments of the veterinary medicine and diagnostics industry and public research, as well as biotechnology companies (start-ups).

By enabling face-to-face encounters, the event will enhance the visibility of cutting-edge research in France and in Europe, encourage investments, and lead to therapeutic innovation.

ORGANISED BY

ARE YOU INTERESTED IN HAVING YOUR EVENT HOSTED DURING BIOFIT 2017?

Feel free to contact us to discuss a potential partnership. Hosting your event during BioFIT is a win-win agreement that gives the opportunity to your participants to access BioFIT.

I want to host an event during BioFIT

Check out BioFIT 2017’s hosted event Read More »

Scroll to Top
  • No products in the cart.